Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study

Smith, 2001, J Am Coll Cardiol, 37, 2215, 10.1016/S0735-1097(01)01344-4

Popma, 2001, Antithrombotic therapy in patients undergoing percutaneous coronary intervention, Chest, 119, 321S, 10.1378/chest.119.1_suppl.321S

Fox, 2007, Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE), Heart, 93, 177, 10.1136/hrt.2005.084830

Van de Werf, 2005, Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study, BMJ, 330, 441, 10.1136/bmj.38335.390718.82

Ryan, 2005, Circulation, 112, 3049, 10.1161/CIRCULATIONAHA.105.582346

Hordijk-Trion, 2006, Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization, Eur Heart J, 27, 671, 10.1093/eurheartj/ehi731

Montalescot, 2005, Description of modern practices of percutaneous coronary intervention and identification of risk factors for adverse outcome in the French nationwide OPEN registry, Heart, 91, 89, 10.1136/hrt.2003.021402

Williams, 2000, Percutaneous coronary intervention in the current era compared with 1985–1986: the National Heart, Lung, and Blood Institute Registries, Circulation, 102, 2945, 10.1161/01.CIR.102.24.2945

Ross, 2003, Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial, J Am Coll Cardiol, 42, 981, 10.1016/S0735-1097(03)00913-6

Blankenship, 2006, Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy), Am J Cardiol, 97, 1591, 10.1016/j.amjcard.2005.12.050

Wu, 2006, A risk score to predict in-hospital mortality for percutaneous coronary interventions, J Am Coll Cardiol, 47, 654, 10.1016/j.jacc.2005.09.071

Palmerini, 2006, Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry), Am J Cardiol, 98, 54, 10.1016/j.amjcard.2006.01.070

Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138

Lincoff, 2003, Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial, JAMA, 289, 853, 10.1001/jama.289.7.853

Montalescot, 2006, Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention, N Engl J Med, 355, 1006, 10.1056/NEJMoa052711

Yusuf, 2006, Comparison of fondaparinux and enoxaparin in acute coronary syndromes, N Engl J Med, 354, 1464, 10.1056/NEJMoa055443

Yusuf, 2006, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, 295, 1519, 10.1001/jama.295.13.joc60038

Anderson, 2002, A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), J Am Coll Cardiol, 39, 1096, 10.1016/S0735-1097(02)01733-3

Srinivas, 2002, Circulation, 106, 1627, 10.1161/01.CIR.0000031570.27023.79

Bhatt, 2003, Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study, J Am Coll Cardiol, 41, 20, 10.1016/S0735-1097(02)02631-1

Serruys, 2002, Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial, JAMA, 287, 3215, 10.1001/jama.287.24.3215

Petersen, 2004, Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview, JAMA, 292, 89, 10.1001/jama.292.1.89

Agostoni, 2004, Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials, J Am Coll Cardiol, 44, 349, 10.1016/j.jacc.2004.04.034

Young, 2000, Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators, J Invasive Cardiol, 12, E14

Ferguson, 2004, Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial, JAMA, 292, 45, 10.1001/jama.292.1.45